AnaptysBio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
32.50
|
|
Average Rating
|
3.25
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
5
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.72
|
-1.18
|
-0.46
|
-63.89%
|
|
2022-06-30
|
-1.02
|
-1.15
|
-0.13
|
-12.75%
|
|
2022-03-31
|
-0.99
|
-1.31
|
-0.32
|
-32.32%
|
|
2021-12-31
|
2.57
|
-1.13
|
-3.70
|
-143.97%
|
|
2021-09-30
|
-0.91
|
-0.24
|
0.67
|
73.63%
|
|
2021-06-30
|
-0.11
|
-0.02
|
0.09
|
81.82%
|
|
2021-03-31
|
-0.69
|
-0.66
|
0.03
|
4.35%
|
|
2020-12-31
|
1.39
|
1.20
|
-0.19
|
-13.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-3.64
|
|
2021-12-31
|
-2.05
|
|
2020-12-31
|
-0.76
|
|
2019-12-31
|
-3.61
|
|
2018-12-31
|
-2.50
|
|
2017-12-31
|
-1.63
|
|
2016-12-31
|
-2.19
|